No Picture
News

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2019 Financial Results

Conference Call and Webcast Scheduled for Tuesday, February 4

SAN DIEGO, Jan. 20, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2019 financial results after the Nasdaq… […]

No Picture
News

Evofem Biosciences Reports Positive Top-Line Results from Phase 2b Study of Amphora® for Prevention of Chlamydia and Gonorrhea in Women

– AMPREVENCE Study Met Primary and Secondary Endpoints – a 50% Relative Risk Reduction in Chlamydia Infection and a 78% Relative Risk Reduction in Gonorrhea Infection Compared to Placebo — Amphora Was Generally Safe and Well Tolerated; Consistent with… […]